Agilent Technologies, Inc.

Agilent Technologies, Inc. is a global leader in analytical and clinical laboratory technologies, providing instruments, software, services, and consumables for laboratories worldwide. Headquartered in Santa Clara, California, the company's mission is to advance the quality of life by delivering trusted answers and insights that enable customers to advance scientific discovery and improve human health.

Agilent's comprehensive portfolio includes advanced analytical instruments such as gas and liquid chromatography systems, mass spectrometers, and spectroscopy tools, alongside automation and cell analysis systems. The company also provides essential software for data analysis and laboratory management, a wide range of services including equipment maintenance and technical support, and consumables like bioreagents, columns, and reagents. These solutions serve diverse market segments, including life sciences, diagnostics, and applied chemical markets, encompassing pharmaceutical, biotechnology, academic and government research, food safety, environmental testing, and advanced materials.

Padraig McDonnell assumed the role of President and CEO in May 2024. Agilent reported solid financial performance for the first quarter of fiscal year 2026, with revenue increasing by 7.0% year-over-year to $1.80 billion, and subsequently raised its full fiscal year 2026 revenue outlook to a range of $7.3 billion to $7.5 billion. Recent strategic activities in March 2026 include the acquisition of Biocare Medical, a leader in clinical and research pathology solutions, and receiving FDA approval for its PD-L1 IHC 22C3 pharmDx in esophageal or gastroesophageal junction (GEJ) carcinoma.